Apellis Pharmaceuticals to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) will present at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 1:20 p.m. ET. The presentation will feature a fireside chat with co-founder and CEO Cedric Francois, M.D., Ph.D. The event is set to take place virtually and can be accessed live via the company's website. A replay of the webcast will be available for 90 days post-event. Apellis focuses on pioneering targeted C3 therapies aimed at treating debilitating diseases arising from excessive activation of the complement cascade.

WALTHAM, Mass., June 04, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that the company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11, 2020 at 1:20 p.m. ET. The conference will be held in a virtual meeting format.

Cedric Francois, M.D., Ph.D., co-founder and chief executive officer of Apellis, will participate in a fireside chat. The event will be available live via webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. By pioneering targeted C3 therapies, we aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.

Investor Contact:
Sam Martin / Maghan Meyers
Argot Partners
sam@argotpartners.com/ maghan@argotpartners.com
212.600.1902

FAQ

When will Apellis Pharmaceuticals present at the Goldman Sachs Global Healthcare Conference?

Apellis Pharmaceuticals will present on June 11, 2020, at 1:20 p.m. ET.

Who will represent Apellis Pharmaceuticals at the conference?

Cedric Francois, M.D., Ph.D., co-founder and CEO of Apellis, will participate in a fireside chat.

How can I watch the Apellis Pharmaceuticals presentation?

The presentation can be watched live on the 'Events and Presentations' page of Apellis' website.

Will there be a replay of the Apellis Pharmaceuticals event?

Yes, a replay of the webcast will be available for 90 days following the event.

What is the focus of Apellis Pharmaceuticals?

Apellis Pharmaceuticals specializes in developing targeted C3 therapies for various debilitating diseases.